prior to now number of years, the UK has witnessed a revolution in clinical bodyweight‑reduction treatment plans — with the introduction of semaglutide (Wegovy®) towards the rising popularity of tirzepatide (Mounjaro®). Now, A further title is drawing awareness in each medical and community welln